Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/Yescarta-Receives-U-S-FDA-Approval-as-First-CAR-T-cell-Therapy-for-Initial-Treatment-of-Relapsed-39943312/?utm_source=whatsapp&utm_medium=social&utm_campaign=share